Description of the blood test:

The Cytomegalovirus (CMV) IgG test is a serological laboratory study used to determine the presence of long-term antibodies against CMV, a common virus in the herpes family. Once a person is infected, the virus remains in the body for life in a dormant (latent) state. The presence of IgG antibodies indicates that the individual has encountered the virus in the past or is a chronic carrier. For the majority of healthy adults, a positive result is normal; however, monitoring these levels is critically important for pregnant women and immunocompromised patients to assess the risk of viral reactivation or primary infection.

What does the analysis represent?

• Immune Status: Determines if the patient has a baseline immunity or is a “seronegative” individual at risk for primary infection.
• Past Exposure: Acts as a marker of a historical encounter with the virus, distinguishing it from an acute, first-time infection.
• Risk Assessment: Essential for screening prior to organ transplantation or during pregnancy planning to establish the patient’s viral profile.
• Performance: High-precision enzyme immunoassay (ELISA) of a venous blood sample.

Recommendations for the test (General)

• Time: Blood should ideally be collected during the morning hours.
• Fasting: A food intake pause of 4 to 8 hours is recommended for optimal accuracy.
• Rest: Patients should remain in a calm state for 15–20 minutes prior to the procedure to avoid stress-induced physiological changes.
• Important: A single IgG test cannot determine exactly when the infection occurred; it only confirms that the immune system has recognized the virus at some point.

What can affect the results?

• Medical History: Recent blood transfusions or the administration of intravenous immunoglobulins can lead to temporary false-positive results.
• Immune Suppression: In patients with advanced immune deficiency, IgG levels may be undetectable or abnormally low despite the presence of the virus.
• Cross-reactivity: Occasionally, high levels of antibodies to other herpesviruses (like EBV) can cause minor interference in the assay.

When to take the test?

• Recommendations: Prescribed as part of pre-pregnancy screening, during the evaluation of donors and recipients for transplant, or when investigating chronic fatigue or prolonged fever of unknown origin.
• Preparation: Standard preparation for blood collection; avoid alcohol and fatty foods for 24 hours before the test.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist or an obstetrician-gynecologist. A positive IgG result is a clinical marker of viral memory and is not a final diagnosis of an active health threat. The physician evaluates the quantitative titer and compares it with previous results if available. Only an expert can decide if the detected levels represent stable immunity or if further investigation is needed to rule out a recent reactivation that could impact reproductive or systemic health.

Possible further investigations

• CMV IgM: To rule out or confirm a current, active stage of the infection.
• CMV IgG Avidity: To estimate the “age” of the infection (whether it occurred recently or more than 3–4 months ago).
• CMV DNA PCR (Quantitative): To measure the viral load in the blood if reactivation is suspected.
• Consultation with an Infectious Disease Specialist: To develop an individualized monitoring plan based on your immune profile.

When does the next step make sense?

Understanding your CMV IgG status is a vital step in managing long-term health and pregnancy risks. If the result is positive, the next step is a consultation with a specialist to interpret the clinical significance of the antibody levels and ensure any potential risks are safely managed.

👉 If necessary, you can discuss the test results with our specialized — dermatologist disease specialist (Doctors – TAMC).